Research
The red molecule from microalgae: why astaxanthin interests researchers
Salmon is not pink by nature. Its colour comes from its food: from astaxanthin, a red pigment made mainly by microalgae.1 It reaches fish via krill and prawns. For farmed salmon, trout and prawns, it is added to the feed.1,2
Many texts describe astaxanthin as a particularly strong antioxidant. In the laboratory, this is well studied. The more important question is: what have studies in humans actually measured?
This article sorts the meta-analyses on skin, fertility, blood lipids, weight, liver and memory. And it shows which amount EFSA considered safe in 2020.
What is astaxanthin, and where does it come from?
Astaxanthin is a carotenoid from the xanthophyll group, a fat-soluble pigment. Unlike beta-carotene, the body does not convert it into vitamin A. The same applies to the related xanthophylls lutein and zeaxanthin.1

The main source is the freshwater microalga Haematococcus pluvialis. Under stress, such as nutrient shortage or strong light, it stores astaxanthin, up to 3.8% of its dry weight. It is the main source of the astaxanthin that people consume. There is also synthetically produced astaxanthin. It is not chemically identical to the natural form.1,3
How might astaxanthin work in the body?
The molecule has a long chain of double bonds with polar groups at both ends. This shape allows it to span a cell membrane from the inside to the outside. Where fats in the membrane can be damaged by reactive oxygen compounds (oxidative stress), it could intercept them.1,2
Reviews also describe effects on cell signalling. According to them, astaxanthin influences Nrf2, a switch for the body's own defence against oxidative stress. It also influences NF-κB, a switch for inflammatory signals.2,4 These findings come mostly from cell and animal experiments.

A plausible mechanism is not yet evidence of a benefit in humans.
What matters is what becomes measurable in human studies. The following sections go through the areas one by one.
What do studies show on astaxanthin and skin?
The data on skin are the clearest. A 2021 meta-analysis pooled 9 randomised trials in which astaxanthin was taken by mouth. Participants were 40-50 years old on average, and the trials ran for 4-16 weeks.5
Compared with placebo, skin moisture and elasticity were higher. For wrinkle depth, no difference was established. The trials were small, with 16-65 participants each, and their results on elasticity varied widely.5
Skin and fertility: some measures changed
Astaxanthin compared with the control group, per meta-analysis
Skin · Zhou 2021 · 9 trials, 4-16 weeks
Assisted reproduction · Maleki-Hajiagha 2024
Are there data on astaxanthin and fertility?
Yes, from assisted reproduction. A 2024 meta-analysis found a higher share of mature egg cells in clinical trials and a higher antioxidant capacity in the fluid surrounding the egg cell.6
For pregnancy rates and the other outcomes, no difference was established. The authors name the limits themselves: few, small and heterogeneous trials with a risk of bias.6
Does astaxanthin lower cholesterol or blood sugar?
The data are mixed. A 2015 meta-analysis of 7 randomised trials with 280 participants found no established difference in total cholesterol, LDL, HDL and triglycerides. Blood sugar was 2.65 mg/dl lower, which was also not statistically established. The authors read this as a slight reduction that further trials would need to confirm.7
A 2025 meta-analysis looked only at amounts of 6-20 mg per day. In its 8 trials, HDL was higher and triglycerides were lower. LDL and total cholesterol did not differ.8 Here, too, the trials were small and differently designed.
Does astaxanthin help with weight loss?
There is no basis for this. A 2025 meta-analysis of 9 trials found no difference in body weight and BMI. Higher amounts did not change this.9
How does astaxanthin affect liver values?
Not in the way one would expect from an antioxidant. A 2024 meta-analysis pooled 5 trials with 196 participants and 6-12 mg per day. For AST, GGT and alkaline phosphatase (ALP), no difference was established. The liver value ALT was 1.92 U/l higher.10
This is no sign of liver damage. But it is no evidence of liver protection either.10
Blood lipids, weight, liver: mostly no difference
Astaxanthin compared with the control group, per meta-analysis
Blood lipids · Ursoniu 2015 · 7 trials, 280 participants
Blood lipids · Fornari Laurindo 2025 · 8 trials, 6-20 mg
Weight · Laurindo 2025 · 9 trials
Liver · Arefpour 2024 · 5 trials, 196 participants
What about the brain and memory?
There are first signals here, but no robust evidence. A 2024 systematic review of clinical trials in older people reports favourable trends in memory and thinking in most trials. This was not statistically established.11
The trials were small, and some tested astaxanthin together with other substances. Whether an effect is due to astaxanthin cannot be read from them.11
Is there an authorised health claim for astaxanthin?
No. EFSA assessed proposed claims on astaxanthin in 2009 and 2011, including protection of the skin from UV damage, joints, muscle function and protection from oxidative damage.12,13 Astaxanthin is not on the EU list of authorised health claims.14
What studies have measured is therefore not an authorised health claim. How the authorisation procedure works is explained in the article EU health claims.
Which amounts have been studied?
In the skin trials, participants mostly took 4-12 mg per day, in the trials on liver values 6-12 mg.5,10 The trials on blood lipids ranged from 4 to 20 mg.7,8
Astaxanthin is fat-soluble. How much of it is absorbed depends on the fat in the meal, on how the product is formulated and on the individual.2
Trial amounts and the amount EFSA assessed
Astaxanthin in milligrams per day
Is astaxanthin safe?
In 2020, EFSA assessed whether 8 mg per day from food supplements is safe, in addition to astaxanthin from fish and crustaceans. Its conclusion: for adults, this amount is safe. Adolescents aged 14 to 17 reach the acceptable daily intake (ADI) with it. In children aged 10 to 13, intake would be 28% above it.15
8 mg a day: what EFSA found by age
8 mg from food supplements plus astaxanthin from the diet, compared with the acceptable daily intake (ADI)
EFSA 2020
A 2019 safety review assessed 87 human studies with natural astaxanthin. None found safety concerns, and 35 of them used 12 mg or more per day. Depending on the country, recommended or approved amounts ranged from 2 to 24 mg.3 In one trial with a very high amount, stools turned red and bowel movements became more frequent.8
Data on longer periods of use are lacking. The best amount is also open.2
What does this mean overall?
Astaxanthin is a well-studied molecule with a plausible mechanism. In humans, the findings are smaller than its reputation suggests: some skin values changed, blood lipids inconsistent, no benefit for weight or liver values.5,8-10
Other fat-soluble substances regarded as antioxidants are covered in the articles on vitamin E and coenzyme Q10.
Key points
- Astaxanthin is a fat-soluble carotenoid made mainly by microalgae. It turns salmon, krill and prawns red and is not converted into vitamin A.1
- For skin, moisture and elasticity were higher in one meta-analysis, wrinkle depth was unchanged.5
- For blood lipids, the meta-analyses are inconsistent. For weight there was no difference, for liver values no benefit.7-10
- There is no authorised health claim.14
- EFSA considers 8 mg per day from food supplements safe for adults, not for children and adolescents.15
Sources
- Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications - a review. Marine Drugs, 2014.
- Malcangi G, Inchingolo AM, Casamassima L, et al. The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review. International Journal of Molecular Sciences, 2026.
- Brendler T, Williamson EM. Astaxanthin: How much is too much? A safety review. Phytotherapy Research, 2019.
- Donoso A, González-Durán J, Muñoz AA, González PA, Agurto-Muñoz C. Therapeutic uses of natural astaxanthin: an evidence-based review focused on human clinical trials. Pharmacological Research, 2021.
- Zhou X, Cao Q, Orfila C, Zhao J, Zhang L. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. Nutrients, 2021.
- Maleki-Hajiagha A, Shafie A, Maajani K, Amidi F. Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic review and meta-analysis of clinical and animal studies. Journal of Ovarian Research, 2024.
- Ursoniu S, Sahebkar A, Serban MC, Banach M. Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials. Archives of Medical Science, 2015.
- Fornari Laurindo L, Dogani Rodrigues V, Penna Carneiro D, et al. Assessing the Effects of Moderate to High Dosage of Astaxanthin Supplementation on Lipid Profile Parameters - A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Pharmaceuticals, 2025.
- Laurindo LF, Dogani Rodrigues V, Audi M, et al. Therapeutic Potential of Astaxanthin for Body Weight Regulation: A Systematic Review and Meta-Analysis with Dose-Response Assessment. Pharmaceuticals, 2025.
- Arefpour H, Rasaei N, Amini MR, et al. The effects of astaxanthin supplementation on liver enzyme levels: a systematic review and meta-analysis. International Journal for Vitamin and Nutrition Research, 2024.
- Utomo NP, Pinzon RT, Latumahina PK, Damayanti KRS. Astaxanthin and improvement of dementia: A systematic review of current clinical trials. Cerebral Circulation - Cognition and Behavior, 2024.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to astaxanthin and maintenance of joints, tendons, and connective tissue, protection of DNA, proteins and lipids from oxidative damage and further claims pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2009;7(10):1253.
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to astaxanthin and protection of the skin from UV-induced damage, defence against Helicobacter pylori, contribution to normal spermatogenesis, contribution to normal muscle function and “immune system” pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2011;9(6):2206.
- European Commission. Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Consolidated version of 20 August 2025.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Safety of astaxanthin for its use as a novel food in food supplements. EFSA Journal, 2020.
ATLAS All-in-One - 35 ingredients, 4 capsules, once a day.
